A First Draft of the History of Treating Coronavirus Disease 2019: Use of Repurposed Medications in United States Hospitals
Author:
Affiliation:
1. Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Oncology
Link
http://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofaa617/34910993/ofaa617.pdf
Reference26 articles.
1. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia;Li;N Engl J Med,2020
2. Optimizing the trade-off between learning and doing in a pandemic;Angus;JAMA,2020
3. Real-world inpatient use of medications repurposed for COVID-19 in US hospitals, March-May 2020;Kadri;Open Forum Infect Dis,2020
4. COVID-19 investigational treatments in use among hospitalized patients identified through the US coronavirus disease 2019-associated hospitalization surveillance network, March 1-June 30, 2020;Acosta;Open Forum Infect Dis,2020
5. Hydroxychloroquine and chloroquine prescribing patterns by provider specialty following initial reports of potential benefit for COVID-19 treatment—United States, January-June 2020;Bull-Otterson;MMWR Morb Mortal Wkly Rep,2020
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Understanding uptake of information about innovations among emergency department clinicians during the COVID‐19 pandemic;Journal of the American College of Emergency Physicians Open;2024-07-19
2. Efficacy and safety of zapnometinib in hospitalised adult patients with COVID-19 (RESPIRE): a randomised, double-blind, placebo-controlled, multicentre, proof-of-concept, phase 2 trial;eClinicalMedicine;2023-11
3. Incidence and Predictors of COVID-19 Infection in Prison Healthcare Workers;Journal of Occupational & Environmental Medicine;2023-03-07
4. Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting;International Immunopharmacology;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3